Republic of te Depart FFICE BIDS AND AWARDS COMMITTEE [RESOLUTION NO. 2020-071-B 11 February 2020 RECOMMENDING OF APPROVAL OF AWARD OF CONTRACT FOR ITEM NOS.2 AND 6 OF THE PROCUREMENT OF VARIOUS DRUGS AND MEDICINES ‘Quant 72,000,000 sion_| 25,000 7,000,000 | CapsulerTabiet 7,684 | Treatment Pack Clonidine 700,000 | Tabet Povidone loging $000 | Bote - TOTAL | _3512477.20 /HEREAS, on 02 September 2019, « Purchase Request (PR) fr Item No, 6 Povidone line 9s received from Health Emergency Management Bureay (HEMB); No.4 Glilazide was received ftom Disease ted Disease Division (LRDD) /HERPAS, on 16 September 2019, « PR for swention and Contol Bureau (DPCB) - LH-Ré /HEREAS, on 17 September tcted at 10:00 AM at the Ci seuss the detail a Presprocurement Conference for Kem No. 6 sas \C Conference Room, Department of Heath (DOH) #0 the procurement at hand: /HEREAS, on 18 September 2019, PRS for ler No.1 Paracetamol 500mg Tabk racetamol Suspension and lem No. 5 Clonidine were received fom HEMB, /HEREAS, on 23 September 2019, the Cental Office Bids and Avs =A issued » memorandum to HEMB requesting for the submission of sed on the discusjon/comments during the Pe-procurement Confere Commitee (COBAC) PR for lem No.6 /HEREAS, on 26 September 2019, revised PR for lem No, 6 was rssived from HEME, /HEREAS, on 01 October 2019, a Pre-procurement Conference fo tem Nos. 1,2, 4 and $ was BAC Conference Room, DOH to discuss the details ofthe 'HEREAS, on 02 October 2019, 2 PR for lem No, 3 Mefenamic Acid was received from iEMB; rector?WHEREAS, on 08 October 201 [EMB requesting for the sb WHEREAS, on 14 October 2019, 1 10:00 AM atthe COBAC Cont Tad iEMB WHEREAS, on 18 October 2019, WHEREAS, on 21 Ociober 2019, procurement Conference /HEREAS, on the same dat urement Conference; edicnes and Maintenance Mei imuovs period of sever PRIIGEPS website: cOBAC - A of revised PRS <@scussion comments during the Pre-procurement Confrence: ocurement Conference for tem No. 3 was conducted rom, DOH to discuss the details of the procurement at WHEREAS, on 17 October 2019, revised PRs for Hem No. 1, 2 and 5 were recived fom ised PR for Item No.4 was received from DPCB-LRDD: the COBAC-A issued ¢ memorandum to HEME requesting 3 the submission of revised PR for tem No. 3 based on the discussion comments during the her memorandum was isued to DPCB-LRDD to follow-up submission of revised PR for Item No.4 based oa the diseussioncomments during the Pre- WHEREAS, on 05 November 2019, HEMB submited its revised PR for tem No.3; WHEREAS, during the Procurement Service Year-End Review, it was instructed that HEMB's 3s will be procured through Framework Agreement; /HEREAS, the Technial Working Group (TWG) was crested through the issuance of }partment Personnel Order (DPO) COBAC No, 2020-052 dated 6 December 2019, VHEREAS, Bid Bulletin No. 1, dated 06 December 2018, wat issued 9 announce the new ct changes made in the Bidding Documents posted in the /HEREAS, on 17 December 2019, a Pre-idding Conference took places re-scheduled at 10:00 AM atthe COBAC Conferen ted Conference, to wit: Room, DOH, with sx (6) prospective bidders attending theVHEREAS, during the ing Conference, clarifications on the Eli ere discussed; VHEREAS, on 19 December 2019, the Mines of the Pre-Bidding Conference was posted in {he DOH website IHEREAS, on 20 December 2019, a memorandum was issved to DPCB and HEME relative to ‘he comments made on the Schedule of Requirements 'HEREAS, onthe same date, a memorandum was received from DPCB that they will nt make 3 mod the delivery schedule for tem No. 4 WHEREAS, on 27 December 2018, a ene livery schedule int snty (60) calendar dy received from PPI requesting to change the item Nos. 1,3, and $; 2, dated 02 January 2020, was issued to announce the the Submission and Opening of Bide on 07 January 2020, the request for clarification was refered to HEMB through luring the 10" Regular Meeting, the COBAC-A was informed as refered 10 the End-user and the Committee noted the aria-in-charge to acknowledge the above-cted let WHEREAS, on the same date, during the above-ited activity, the memorandum rossived from )PCE last 20 December 2019 wa presented tothe COBAC-A snd noted the information, VHEREAS, on 0§ January 2020, an acknowledgement letter was issued to PPI through fesimile and electronic mail (email), WHEREAS, on 09 January 2020, the response to request for clarification and revised PRs for Hem Nos. 1,23, and $ were received from HEM; -AS, Bid Bulletin No.3, dated tivities, and to reflet the changes made fanuary 2020, to announce the new schoiule of the Bidding Decuments posted inthe PhIGEPS YHEREAS, on 14 January 202, the response of HEMB and the revised PRs were presented 0 the COBAC’A during its 11® Regular Meeting and was informed that a Bid Bulletin was alcady ‘asued forthe changes. The Committee noted the information, /HEREAS, on ‘Three (3) prospos spective propos january 2020, th Submission of Bids took place as re-scheduld at 9:00 AM, bidders procured the bidding documents and subsequently submited thei 1, EPI Joint Venture (JV) with Roymed Pharmaceutical (RP); resterdIne. (UNILAB). Tama FLIGIBLET | ELIGIBLE | ELI PASSED | PASSED | PASSED Nar | tem Devron| 0. | tai] Thnes DID PRICE AS READ (PP) 1 oan000 | tabi | o0nnn00 | sango00 | eoeo0000 | NOBID 2 2so00 | sdae | 35125000| 3250000 | NowID | NoBID 3 sa | 200000 nos | sos | NopiD |) cumate | | 780 nos | nomi | NoBiD S| Giine — | iooo0 noma srao0 | Povidne aie [- 000 ‘70000 | N01 ‘NOBID WHEREAS, the COBAC-A declan 6, subject to farther arithmet est-qulifieation; /HEREAS, the COBAC Resolution No, 2020-071, “Declarti fs. 3 and forthe Procurement of Various Drugs nd Medi the COBAC Resous Kem Nos. 1 and 5 a of Bd of tomatone ig Fa WHEREAS, on 24 January 202 alulaed, 1 Wit Hem No.2: 25,000 bottles the TWG ~ Financial subminod the Abstract of Bids as Paracetamol Suspension S| ameotcompany | _ancerary | 1 [BPE wi P| 35425000 | 395, em No.6: 4,000 bottles of Povidone Iodine Bidder der | Name of Company Bid as Calculated | ~% Variunce ABC (PHP) ‘rom ABC r EPLIV with RP T3ES60O0 27.22% WHEREAS, on 2 THEREAS, on the same date the submission ofthe pos lendar days upon receipt ofthe WHEREAS, on 31 January 2020, thin the prescribed period: WHEREAS, on 0§ February requirements and post-gualifict (Go verily, validate and ascet VHEREAS, on the same date, "Responsive": WHEREAS, on the same date, the recommendation and declared EPI IREAS, on 07 February 20 fons specified in the bidding fegular Meeting. Upon review and deli sion Repo BEPQR) cing E the Commie decided to n of the Single Calelsted Bidder for Item Nos. 2 and 6, COBAC-A issued a eter to EPIJV with RP requesting for ion requirments with ndible period of Five (5) PIV with RP submited the Post-qulification documents 020, the detsled evaluation of the eligibility, technical ‘documents of the SCB were underaken by the designated in he documents submited by the SC; “TWO sibmited their report desasing EPI IV with RP as cited seport was presented tothe COBAC-A during its 14% ‘ommittee concured with the TWO NV with RP 0, Evaluation and Post: all he requirements andF deliberated the TWG reports as wall as the documents submitid by the SCB for the items listed below and the following ate the salient points of the ‘etberation: ‘Name of [Bidders Tem COBACA No, | Peserition | piader | Rank | ABC (PHP) | Bid Price (PhP) Revommendation Finding ‘Recommendation 2 | 28000 —Pertv | sce "35428000" ) 325,000.00 Resporsive |» COBAC-A confonms Single Calculated Dotles of | with RP withthe and Responsive Paracetamol [to have complied with recommendaion of | Bidder (SCRB) Suspension ‘the legal, technical and the TWA, © | ooo bois 1356000 | 97700.00 | Financial requirements ‘of Povidone Tovine determined 10 be responsive and. have complied 10 all the requirements and conditions = specified inthe Philippine Bidding | Documents and recommended forthe | fward ofconact, | WHEREAS, a the time of signing ofthis Resolution, there is no pending incident, no pending Request for Reconsideration, no pening protest nd the COBAC-A followed the requirements set forth in RA 9184;(OW THEREFORE, on the [MARIA SOLEDAD. ANTONIO, MD, PhD, MPH, DPAFP,CESE ‘Scan a. [NESTOR F. Assistant Secretary of Health Chairperson Authority of the Secretary of sith MAR 03 2020 \. MPH, CEO VI, CESO IIL PHL CESE, |LBONIT{P.GORGOLON MD, MA, MCHM,CEO VI Regular Member IAGO, JR, MD, MPH, MBSA, CESO TIL esters